Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.
about
How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?Advances in antibiotic therapy in the critically illClostridium difficile infection: a review of current and emerging therapiesFecal microbiota transplantation: current clinical efficacy and future prospectsClinical Utility of Laboratory Detection of Clostridium difficile Strain BI/NAP1/027Tracking Inhibitory Alterations during Interstrain Clostridium difficile Interactions by Monitoring Cell Envelope Capacitance.Advances in the Microbiome: Applications to Clostridium difficile InfectionAsymptomatic Clostridium difficile colonization: epidemiology and clinical implicationsHarbouring public good mutants within a pathogen population can increase both fitness and virulenceClostridium difficile infection: Updates in management.A Review of Experimental and Off-Label Therapies for Clostridium difficile InfectionFaecal microbiota transplant for recurrent Clostridium difficile infection using long-term frozen stool is effective: clinical efficacy and bacterial viability data.Antimicrobial susceptibility of Clostridium difficile isolated in ThailandNovel approaches to treating Clostridium difficile-associated colitis.Breakthroughs in the treatment and prevention of Clostridium difficile infection.A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection.Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection.Colonization Resistance of the Gut Microbiota against Clostridium difficile.Understanding the mechanisms of faecal microbiota transplantation.Fecal Transplants: What Is Being Transferred?Biome engineering-2020.Clostridium difficile colitis: pathogenesis and host defencePrecision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota.The non-toxigenic Clostridium difficile CD37 protects mice against infection with a BI/NAP1/027 type of C. difficile strain.Prevalence and molecular epidemiology of Clostridium difficile infection in IndonesiaGenome-Based Infection Tracking Reveals Dynamics of Clostridium difficile Transmission and Disease Recurrence.Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel DiseaseAccessory Gene Regulator-1 Locus Is Essential for Virulence and Pathogenesis of Clostridium difficileAn assessment of the future impact of alternative technologies on antibiotics markets.Pathogenesis of Clostridium difficile Infection and Its Potential Role in Inflammatory Bowel Disease.Nonantimicrobial drug targets for Clostridium difficile infections.Bezlotoxumab: anti-toxin B monoclonal antibody to prevent recurrence of Clostridium difficile infection.Mucosal Antibodies to the C Terminus of Toxin A Prevent Colonization of Clostridium difficile.Therapies on the horizon for Clostridium difficile infections.Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review.Antimicrobial Use, Human Gut Microbiota and Clostridium difficile Colonization and Infection.A Review of Management of Clostridium difficile Infection: Primary and Recurrence.Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.Consensus report: faecal microbiota transfer - clinical applications and procedures.
P2860
Q26748155-6F5DE373-6E1F-43E6-99B4-C7DC34C8EC6AQ26749328-52B16AD4-7F99-475C-9464-A1A2B50583A9Q26750157-F7460EB2-5AE3-414A-93FC-A5CA0F3D9D06Q26777245-BE8189D9-8B9C-4202-88F6-20870C0AE04EQ26778127-955B7D10-D150-41BF-B5D3-1775B0259EC1Q27300282-C360ADE7-EDD8-453A-B5D6-D90FC909BFC1Q28066362-F0D53DB5-0671-4216-A5ED-E03895EB50D4Q28083860-AF43C5C8-166E-4B0C-B681-8D36F19C8240Q28354993-4A0C9DBE-8850-4D3D-8020-3A2D6D1D0EA4Q30239988-96929989-23AF-458B-ADDB-6B0A466B9A04Q30240264-734F0AEB-24C8-4AEE-AB8E-1834695C1374Q30986751-A9C5F8BB-553E-470A-B64F-67FD7E9C6024Q33781513-21DE2098-7A85-48B1-AF1F-A5F1A5DA8A89Q35862915-1029D781-B0D0-436C-AB2E-4C3344920DDEQ35918566-0DD698E6-77E8-4E6C-A0A1-0D4FFD78EA4EQ35933501-A8765BEB-45E7-4C46-9B19-79D15D2CF8E3Q35956651-17D9A3C2-162E-4E79-94BE-5DAA887D3742Q35973168-F035AF2F-9F9B-4336-8C49-2FEECB809D1CQ36058419-0599E26C-9072-4667-9E2A-A35453125C90Q36073899-AA2692DD-7427-4B54-B117-1F3062E26FD4Q36089258-8B97EAED-0CBB-40C9-A59E-12EC4B7808D1Q36116428-209F7E1A-FFC6-4C9D-9F8D-77D78C529526Q36148926-3EB7149B-3A71-4832-9EFC-ADF681FE93FAQ36328439-62569F95-B398-4E52-8573-D8D5586FC489Q36398819-3859B6D8-1BD3-428D-A778-DD1F3876319CQ36635701-A824F91B-7058-48D7-812A-D37BC2A9133EQ37014160-9ABCC0CC-E761-4126-A260-CAA52E00443EQ37193442-04464D8F-C1F5-4856-83E5-802D44089601Q37367183-29F18BF5-A84C-4642-BF09-40949D2D37AFQ38551892-6738306C-1B26-4EA8-90CF-EAD033B37928Q38649348-90764A4B-02A5-41E9-A4C1-C80BB5C266EFQ38668483-7A227534-46A5-4855-A706-DE3452BFABF4Q38717600-44846607-1B52-45A6-A4BD-173EF72719A1Q38757930-22AD27EF-EA81-4934-BDCE-F90F634EE286Q38764998-A9BBC2AE-EF45-4591-81D1-1233EF421F74Q38792828-A410F790-DCD7-4B1B-83B8-1EA1609B80D4Q38792836-9175B5EB-8179-4DEC-AF51-B2119B497772Q38794312-7801D712-5797-42F4-8079-357F7D0A853FQ38933717-DCF9B3C3-ED2F-48B7-B393-EC6DC5FA52BDQ39021811-55C75939-90AE-460F-AA2E-2A115D808D34
P2860
Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Administration of spores of no ...... : a randomized clinical trial.
@en
type
label
Administration of spores of no ...... : a randomized clinical trial.
@en
prefLabel
Administration of spores of no ...... : a randomized clinical trial.
@en
P2093
P356
P1476
Administration of spores of no ...... : a randomized clinical trial.
@en
P2093
Andre Poirier
Antonio Ramos
Christine Lee
Darrell S Pardi
Hongzi Chen
Michelle A Barron
Stephen Villano
Stuart H Cohen
Thomas Meyer
Trevor C Van Schooneveld
P304
P356
10.1001/JAMA.2015.3725
P407
P577
2015-05-01T00:00:00Z